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THE EFFECT OF INSULIN AND CALCITONIN ON OSTEOBLAST 
PROLIFERATION AND BIOMINERALIZATION 
 
AHMAD Y A A ALALI 
Boston University, Henry M. Goldman School of Dental Medicine, 2021 




Objective: Insulin and calcitonin are involved in bone remodeling. Our aim was to 
determine the effect of insulin and calcitonin when added separately and in combination to 
mouse calvarial cultures on osteoblast proliferation and osteoblast mediated 
biomineralization in medium containing ascorbic acid and beta-glycerol phosphate. Our 
hypothesis is that both hormones in combination will cause a synergistic increase in 
osteoblast proliferation and biomineralization.  
Methods: Osteoblasts were isolated from neonatal mouse calvaria and cultured under 
conditions that allow quantification of cellular proliferation and biomineralization. In our 
proliferation model, osteoblasts were grown in medium containing fetal calf serum 
stimulated by insulin, calcitonin, both, or culture medium alone that served as control. 
Proliferation was measured using a hemocytometer (Neubauer cell chamber). Osteoblast 
biomineralization was estimated by assessing cellular calcium uptake and secreted alkaline 
phosphatase activity. In the biomineralization model, osteoblasts were grown in the 
presence of ascorbic acid and betaglycerol phosphate and stimulated by factors used in the 
 vii 
proliferation study. Calcium uptake was measured by an Arsenazo III microplate calcium 
assay and alkaline phosphatase activity was measured by enzyme release from the calvarial 
cellular layer. Histological and quantitative histomorphometric evaluations measured 
mineral deposition. 
Results: Osteoblast proliferation was significantly increased by insulin or calcitonin alone 
but not by both together. All treatments, especially calcitonin, significantly increased 
calcium uptake. Only the combination of insulin and calcitonin significantly increased 
alkaline phosphatase activity.  
Discussion: Our findings suggest that insulin and calcitonin increase proliferation and 
biomineralization controlled by osteoblasts. 
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1.1.   BONE REMODELING AND FUNCTION 
Bone is an active connective tissue that plays a pivotal role in our body throughout 
life. Some of its important functions include calcium and phosphate storage, body support, 
organ protection, movement, and blood cell production (Robling et al. 2006; Datta et al. 
2008). Bone consists of 70% inorganic components, 20% organic components (mostly 
collagen type I), and 10% water. Old bone is constantly replaced with new bone in bone 
remodeling controlled by bone-forming osteoblasts and bone-resorbing osteoclasts 
(Capulli et al. 2014). Bone remodeling that couples resorption and formation serves an 
important role in maintaining bone volume and strength. 
1.2.   OSTEOBLAST MORPHOLOGY AND FUNCTION 
Mesenchymal stem cells in the axial skeleton and ectomesenchymal stem cells in 
the head give rise to osteoblasts. Osteoblasts occur as a single row of cells characterized 
morphologically as cuboidal shaped cells with a distinct round prominent nucleus and 
ample rough endoplasmic reticulum.  In addition, a large Golgi apparatus contains fibrillar 
components that may represent pro-collagen and proteoglycans (Nakamura 2007). 
Osteoblast formation starts when mesenchymal stem cells are stimulated to differentiate by 
Bone Morphogenic Proteins (BMP) and Runt-related transcription factor (Runx2) 
pathways to yield osteoprogenitor cells. When Runx2, proteoglycans and collagen type 1 
are present osteoblast progenitor cells proliferate and become pre-osteoblasts that produce 
alkaline phosphatase (ALP) and secrete bone matrix proteins. During this stage, non-
mineralized bone matrix, called osteoid, is formed. The preosteoblast then differentiates to 
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osteoblasts that involves expression of osteocalcin (OCN) and collagen type I. After 
differentiation, mature osteoblasts can undergo multiple pathways (Capulli et al. 2014). 
Some osteoblasts induce mineralization by producing ALP and forming hydroxyapatite 
crystals. Others undergo apoptosis or become osteocytes buried in bone matrix. Osteocytes 
are the most abundant cells in bone and can receive and transduce mechanical stress to 
affect metabolism. Some osteoblasts become bone lining cells, which are flattened cells 
found on bone surfaces and possibly prevent interaction between osteoclasts and the bone 
matrix to prevent unnecessary bone resorption (Ypey et al. 1992). Osteoblasts also regulate 
osteoclast formation to control bone remodeling (Capulli et al. 2014). Osteoclast 
differentiation depends on interactions between Receptor Activator of Nuclear Kappa B 
Ligand (RANKL) produced by osteoblasts and RANK on preosteoclasts (Lacey et al. 
1998). Osteoprotegrin,(OPG) also produced by osteoblasts, is a decoy receptor that inhibits 
osteoclastogenesis by binding to RANKL and preventing RANK-RANKL binding 
(Simonet et al. 1997).  Finally, recent studies found that osteoblasts are involved in 
hematopoietic stem cell homeostasis (Calvi et al. 2003).  
1.3.   FACTORS AFFECTING OSTEOBLAST DIFFERENTIATION 
Runx2 has an important role in osteoblast differentiation. In mice with genetically 
suppressed Runx2, chondrocytes fail to hypertrophy leading to lack of osteoblast formation 
(Komori et al. 1997). In addition, human beings with an autosomal dominant condition 
called cleidocranial dysplasia which involves abnormalities in bone formation have a 
mutation in Runx2 (Lee et al. 1997). Runx2 overexpression inhibits osteoblast maturation 
leading to osteopenia (Liu et al. 2001). A family of glycoproteins called Wingless (Wnt) 
proteins, especially type 5a and 10, have important roles in osteoblast differentiation 
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(Bennet et al. 2005). BMP’s, part of the Transforming Growth Factor Beta (TGFb) 
superfamily, stimulate Runx2 and other transcription factors to enhance osteogenesis. Both 
BMP-2 and BMP4 prevent impairment of osteogenesis (Bandyopadhyay et al. 2006), and 
BMP7 was shown to increase ALP activity and trigger bone mineralization (Shen et al. 
2010). 
1.4.   BONE MINERALIZATION 
Biomineralization involves the deposition of calcium and phosphate into the 
extracellular matrix of bone, cartilage, and dentin. Mineralization starts with the 
accumulation of calcium and phosphate hydroxyapatite crystals inside matrix vesicles and 
their secretion into the extracellular space between collagen fibrils in bone (Andersson 
2007). An adequate amount of inorganic phosphate is necessary for biomineralization. 
ALP activity is a marker for osteoblast and bone formation. ALP hydrolyzes 
pyrophosphate which removes an inhibitor of hydroxyapatite formation and increases the 
amount of available inorganic phosphate Human ALP is classified into 4 types: tissue 
nonspecific, intestinal, placental, and germ cell. The tissue-nonspecific type is expressed 
on the cell membrane of osteoblasts (Miao and Scutt 2002). ALP functions in the initial 
phase of bone development and declines in mature bone. Runx2 and BMP are the main 
regulators of ALP to initiate calcification. Patients diagnosed with hypophosphatasia may 
have a gene mutation that leads to decreased ALP activity (Golub and Battaglia 2007). 
Bone ALP is specific for osteoblasts and a good marker for bone formation (Gamero and 





1.5.   INSULIN AND OSTEOBLASTS 
Insulin is a hormone secreted by ß-cells of pancreatic islets that is necessary for 
glucose transport into cells. Both osteoblasts and osteoclasts have insulin receptors on their 
surface (Conte et al. 2018). Insulin is required for osteoblast proliferation, survival, 
differentiation, collagen synthesis, alkaline phosphatase production, and glucose uptake 
(Fulzele et al. 2010). Osteoblast differentiation is regulated by insulin through suppression 
of Twist2, a Runx2 inhibitor (Bialek et al. 2004). In addition, insulin reduces osteoclast 
activity. Insulin deficiency leads to reduced mineralized surface area, osteoid surface, 
osteoblast quantity and activity (Thraikill et al. 2005). Diabetic patients with insulin 
deficiency experience low bone mineral density (Janghorbani et al. 2007) and are more 
prone to bone fracture compared to healthy individuals (Hough et al. 2016). The 
relationship between insulin and bone metabolism remains unclear. Hyperinsulinemia in 
the absence of hyperglycemia may lead to reduced bone turnover that may increase BMD 
and cortical porosity causing bone fragility (Huang et al. 2010). 
 
1.6.   CALCITONIN AND OSTEOBLASTS 
Calcitonin is a hormone secreted by parafollicular cells of the thyroid in mammals 
in response to increased blood calcium levels (Naot et al. 2019). Calcitonin is a potent 
inhibitor of bone resorption and was used clinically to treat osteoporosis until the discovery 
of more potent bone resorption inhibitors. Osteoclast inhibition by calcitonin occurs 
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through phosphorylation and altered intracellular distribution of two highly expressed 
proteins, the Src gene product and a tyrosine kinase called Pyk2, found on the cell surface. 
Dephosphorylation of Pyk2 prevents Src and Cbl expression, leading to reduced osteoclast 
motility (Shyu et al. 2007). In addition, Src kinase and Cbl proteins influence osteoclast 
differentiation and function (Zang et al. 2002). In vitro studies found that calcitonin has an 
inhibitory effect on osteoclasts and positively influences osteoblast proliferation and bone 
formation. Administration of calcitonin during the initial phase of bone formation 
stimulates osteoblast proliferation and bone formation (Farley et al. 1988, Villa et al. 
2003). Other studies found that administration of calcitonin after the initiation of bone 
formation had an inhibitory effect (Weiss et al. 1981). Calcitonin had no effect on 
proliferation of primary rat osteoblasts in culture and did not alter bone formation in adult 
mice (Cornish et al. 1995; Cornish et al. 2000). 
 
1.7.   ASCORBIC ACID AND BETA GLYCEROL PHOSPHATE 
Ascorbic acid (AA) is essential for collagen synthesis (Berg et al. 1983), 
collagenase inhibition (Choong et al. 1993), and proline and lysine hydroxylation in pro-
collagen; If AA is absent, proline will be under-hydroxylated causing improper collagen 
helical structure and unwinding of the triple helix at body temperature (Vater et al. 2011). 
Osteoblasts must be in contact with collagen before differentiation, allowing binding by 
integrins, and activation of pathways that lead to osteoblast differentiation (Handschel et 
al. 2010). Activation of ALP, which is involved in calcification of bone matrix, is also 
influenced by AA indirectly as a result of alterations in the regulation of extracellular 
matrix feedback (Choong et al. 1993). 
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Beta-Glycerol Phosphate (BGP) plays an important role in osteogenic differentiation of 
bone marrow stromal cells. It supplies adequate inorganic phosphate for mineralization, 
and induces osteogenic gene expression/BMP 2 by extracellular kinase phosphorylation 
(Tada et al. 2011).  
The effect of AA and BGP on osteoblasts was first tested by Ecarot-Charrier et al. in 1983. 
They added AA, followed by BPG, to osteoblasts isolated from mouse calvaria,. By five to 
six days, mineral deposits were detected on the bone surface. Another study found that 
daily addition of 50ug/ml AA and 10mM BGP for eight days to confluent cell cultures 
resulted in Von-Kossa positive solid deposits indicating mineralization (Benayahu et al. 
1989). Nodular structures with appearance of woven bone were identified in fetal mouse 
calvaria after adding AA and BGP (Bhargava et al. 1988). 
1.8.   STUDY AIMS AND NULL HYPOTHESIS 
The aims of this study were to compare the effect of insulin and calcitonin 
separately and in combination on osteoblast proliferation and osteoblast mediated 
biomineralization. Our hypothesis is that both hormones added in combination will 
synergistically increase osteoblast proliferation and biomineralization.  
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2. MATERIALS AND METHODS 
2.1.   ISOLATION OF PRIMARY OSTEOBLASTS FROM NEONATAL 
CALVARIA 
 All experimental work was done under sterile conditions in a flow cabinet. Ten 
CD-1 mice aged 5-7 days (Charles River Laboratories, MA) were euthanized by cervical 
dislocation and placed in a large petri dish. Cuts were made in the occipital lobe and 
partially in the frontal lobe to produce and release a trapezoid-shaped bone. The calvarial 
fragment was then rinsed in Dulbecco’s modified Eagle medium (DMEM, Gibco™) 
containing 100U/ml penicillin and 100ug/ml streptomycin without fetal calf serum (FCS). 
The calvaria were then placed in a 15ml falcon tube and washed with 5ml phosphate 
buffered-saline (PBS) to remove any residual soft tissue. To remove calcium and 
magnesium from the cell surface, 0.25% trypsin-EDTA (500ul per calvaria) was added and 
incubated for 30 minutes at 37 °C. EDTA with trypsin removes cell to cell adhesion 
molecules. The EDTA-trypsin solution was discarded and the calvaria washed with 5ml 
DMEM. To release osteoblasts, 5ml of 0.2% collagenase solution was added to the 
samples and incubated for 30 minutes at 37 °C. The collagenase solution was discarded 
and replaced with 5ml fresh collagenase solution for further 60 minutes in the incubator at 
37ᵒc to make sure that the cells were released. The collagenase solution was removed and 
the calvaria digest was rinsed with 5ml DMEM to remove any collagenase solution left 
inside the tube and then discarded. The digest was placed with fresh 5ml DMEM and 
centrifuged at 2000rpm for 5 minutes. The supernatant was discarded and the cells were re-
suspended in 10ml DMEM and centrifuged at 2000rpm for 5 minutes. Finally, the cells 
were suspended in 10ml of DMEM and divided into two culture dishes after discarded 
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supernatant. Five ml FCS was added to each dish, the osteoblasts were examined under the 
microscope, and then incubated at 37 °C . 
 
2.2.   TRYPSINIZATION 
 After seven days, the cultures were examined microscopically to assess osteoblast 
attachment to the culture dish. After the cells attached, the DMEM was discarded and the 
cell layer washed with DMEM containing 5mg/ml BSA. Five ml 0.25% trypsin-EDTA 
was added and the cells were incubated for 30 minutes at 37 °C to allow cells to detach. 
When the cells were detached, 6ml FCS DMEM was added and then transferred to a 50ml 
falcon tube and centrifuged for 5 minutes at 2000rpm. The supernatant was discarded and 
36ml of FCS was added and the cells suspended by vortex. Two ml of the suspended cell 
solution was placed in each well of the four 6-well dishes. 
2.3.   PROLIFERATION TESTING 
To determine osteoblast proliferation, a 6-well plate was used for each group: 1) 
control medium only, 2) 500nM of insulin, 3) 40nM of calcitonin, and 4) both 
hormones combined. The four 6-well dishes were incubated at 37 ᵒc. The medium 
was replaced every three days over a 12 day period.  
2.4.    CELL COUNTING 
After 12days culture, four wells were chosen randomly from each 6-well plate for 
cell counting. Trypsin (0.25%) was used to detach osteoblasts from the culture dish. 
Each cell suspension was transferred to a 1.5ml Eppendorf tube and centrifuged at 
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2000rpm for 5 minutes. The cell pellet was resuspended in a 1ml tube and 10ul was 
inserted into a Naubauer hemocytometer glass slide. The osteoblasts were counted 
on a grid scale counting chamber under a microscope with a magnification of 4X. 
 
2.5.   BIOMINERALIZATION TESTING 
Osteoblasts were isolated as described previously. Four 6-well plates were prepared 
for: control medium only, insulin (500nM), calcitonin (40nM), and both hormones 
combined supplemented with following   In addition, 29mg of Vit C was mixed 
with 1ml FCS and 445mg ßGP was mixed with 1ml FCS. Then a solution with 31ul 
of Vit C, 4.5ul of ßGP, and 45ml FCS was prepared; and 2ml of the solution was 
added to each well plate. The cultures were incubated at 37ᵒC and the medium was 
changed every 3 days for a period of 12 days. 
2.6.   VISUALIZING BIOMINERALIZATION 
 After 10 days, one well from each group was chosen randomly and the media was 
removed. The osteoblasts were fixed by adding 1ml of 10% formalin to each well and 
then incubated for 30 minutes without closing the wells cover. Later, the sample wells 
were washed with 1ml distilled water and 1ml 2% silver nitrate was added to all well to 
visualize the calcified areas in each sample. Finally, after 20 minutes incubation, the 
wells were examined microscopically for black spots, indicating the mineralization 
(Liu J et. al., 2013). 
. 
2.7.   CALCIUM ASSAY 
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 The remaining wells from the biomineralization groups were tested for the amount 
of calcium uptake and activity of ALP. The wells were scraped to detach the cells. The 
released cells with the solution was transferred to a 2ml Eppendorf tube and centrifuged for 
5 minutes at 2000rpm. One ml of detergent buffer was added to Tres-HCL buffer. It was 
diluted 20 times and then mixed with Triton x-100. The supernatant was stored in a 
separate Eppendorf tube and the pellet was suspended with 0.5ml of triton solution. The 
solution was mixed by a vortex and allowed to rest on the bench for 1 hour. The samples 
were centrifuged for 5 minutes at 3000rpm and the supernatant placed in a separate tube. 
The second pellet from each group well was suspended with 0.1 M HCL and left on the 
bench for 30 minutes. The pellets were neutralized after 10 minutes by adding 20ul of 0.5 
N NaOH to each sample, they were then centrifuged at 3000rpm, and the pellet was 
discarded. The supernatant was kept for calcium assay. The calcium assay used 1.8mg o-
cresolphthalein Complexone added to 10ml Ammonium Bicarbonate buffer. A 96-well 
microplate was prepared and 20ul of each sample was placed with 180ul of assay mixture 
in each well and incubated at 37ᵒc for 5 minutes. The absorbance was measured at 560nm 
in a  microplate reader (Victor 3, Perkin Elmer).  
2.8.   ASSESSING ALKALINE PHOSPHATASE ACTIVITY 
 ALP activity was determined by production of enzyme from the adherent  
osteoblasts. Cells were detached and the cell lysate were obtained using the lysis buffer 
(0.15 M NaCl/30 mM NaHCO3, pH 8.0, containing 0.5% Nonidet P-40) modified by 
previous article (Lie et.al., 2013). Phosphatase substrate 42mg/10ml was mixed with 10ml 
of NaHCO3 to make 16mM p-nitrophenylphosphate (pNPP, Sigma Co.). 50ul of each 
sample was added to 250ul of PNPP in each well in a 96-well microplate and incubated for 
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30 minutes at 37ᵒc. The 96 well microplate was transferred to a Vector microplate reader 
to measure the absorbance at 405nm. The amount of p-nitrophenol released was calculated 
using the extinction coefficient   
                             ԑ405 nm = 12,500 mol-1 1cm-1                      (Liu et al. 2013) 
to calculate the concentration in mol 1-1 and the rate of hydrolysis using the incubation 
time in mol 1-1 min-1. The alkaline phosphatase activity in µmol 1-1 min-1 was then 
normalized for the protein concentration. 
2.9.   PROTEIN CONTENT DETERMINATION 
BCA™ Protein Assay Kit was used to quantitate the total protein concentration in 
the samples. This assay is a detergent-compatible formulation based on bicinchoninic 
acid (BCA) for spectrophotometric quantitation of total protein. The BCA method is 
based on the following reactions: 
(1) Protein (peptide bonds) + Cu++ → Cu+ 
(2) Cu+ complex + BCA → BCA-Cu+ (purple color) 
The protein concentration of the samples was determined by reference to a standard 
curve generated by dilutions of bovine serum albumin (BSA, ranging from 0-1µg/µl). 
The working reagent was prepared by mixing fifty parts of BCA™ Reagent A (sodium 
carbonate, sodium bicarbonate, bicinchoninic acid and sodium tartrate in 0.1M sodium 
hydroxide) with one part of BCA™ Reagent B (4% cupric sulfate). For analysis, 200µl 
of the working reagent was added to each well and the plate was covered and incubated 
at 37ᵒc for 30 minutes. The absorbance at 562nm was determined using an enzyme-
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linked immunoassay (ELISA) plate reader and the protein concentrations in the 
samples were calculated from the linear regression of the BSA standard curve.  
2.10. STATISTICAL ANALYSIS 
Proliferation and biomineralization data are presented as mean ± S.D.  The statistical 
significance of the difference between controls and test groups were evaluated using 1) 
two-tailed, paired t test with unequal variance, and 2) analysis of variance (ANOVA).  The 
differences between groups were considered statistically significant for p < 0.05. 
3. RESULTS 
3.1.   OSTEOBLASTS PROLIFERATION 
 The data and microscopic analysis for osteoblast proliferation of each group are 
presented in Figure 1A and 1B. The Naubers glass slide consisted of two sides, and each 
side had four counting grid scales, making a total of eight counts for each group. 
Osteoblast proliferation was lowest to highest: control, insulin plus calcitonin, calcitonin, 
and then insulin, respectively. Results are expressed as mean ± S.D. (*, P<0.05, Two-tailed 
t test with unequal variance compared to Control, and ANOVA). Osteoblast proliferation 
significantly increased with addition of either insulin or calcitonin. However, with both 






Anova: Single Factor 
    
SUMMARY 
     




control 4 46.25 11.5625 41.14063 
  
insulin 4 86.75 21.6875 56.10938 
  




4 37.75 9.4375 3.671875 
  
ANOVA 
      
Source of Variation SS df MS F P-value F crit 
Between Groups 421.2686 3 140.4229 4.519566 0.024256 3.490295 
Within Groups 372.8398 12 31.06999 
   
Total 794.1084 15 










Control Insulin Calcitonin Insulin & Calcitonin
Mean Osteoblast Cells Proliferation1A 
Table 1. The mean depths of proliferation rate differ significantly between groups which were subjected to 










Figure 1A. Insulin or Calcitonin significantly increased osteoblasts proliferation compared 
to control (p<0.05). However, Combination of Insulin and Calcitonin had no change of 












Figure 1B. Microscopic observation for osteoblast proliferation. 
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3.2.   BIOMINERALIZATION OF CULTURED PRIMARY OSTEOBLASTS  
The histologic observations for biomineralization of primary neonatal mouse calvarial 
osteoblasts in the presence of ascorbic acid and BGP with either insulin, calcitonin, both, 
or none, are represented in Figure 2. Control cultures with neither insulin nor calcitonin 
did not show mineralized nodules. The significant density of black nodules of mineral 
deposits were clearly visible in cultures maintained in the presence of either insulin, 
calcitonin, or when both agents combined. All magnification were 20x.  
  
Figure 2. Microscopic observation for bone mineralization in the presence of 2% silver nitrate. All 
groups had AA and BGP present. Red circles present areas with mineralization. 
2 
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3.3.   QUANTITATIVE ANAYLSIS OF CALCIUM UPTAKE 
The mineralization results were supported by quantitative changes in cellular calcium 
concentration. Compared to calvarial control, all groups showed a significant increase in 
cumulative calcium uptake, with calcitonin being highest, reflecting high bone 
mineralization. Results are expressed as a mean ± S.D. (*, p<0.05, **, p<0.001, Two-tailed 
t test with unequal variance compared with calvaria control, and ANOVA). The data 


























Figure 3. Comparison of the means and associated standard deviations of osteoblast cells 
calcium uptake for the four groups. From lowest to highest: Control, insulin, insulin and 
calcitonin, and then calcitonin. 
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Anova: Single Factor 
    
SUMMARY 
     




Control 4 0.192449 0.048112 2.26E-05   
Insulin  4 0.276422 0.069106 0.000152 
  
Calcitonin 4 0.490287 0.122572 0.000228 
  
Both  4 0.265014 0.066254 0.000381 
  
ANOVA 
      
Source of Variation SS df MS F P-
value 
F crit 
Between Groups 0.012353 3 0.004118 21.0171 4.55E-
05 
3.490295 
Within Groups 0.002351 12 0.000196 
   
Total 0.014704 15 
    
  Table 2. The mean depths of calcium uptake differ significantly between groups which were subjected to different 
hormones (p < 0.01), compared to control, when tested by ANOVA. 
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3.4.    QUANTITATIVE ANALYSIS OF ALKALINE PHOSPHATASE 
ACTIVITY  
 
Surprisingly, the combined hormones group showed significant increase in ALP 
activity when compared with the control group (p<0.05).  ALP activity in calvaria co-
cultured with either calcitonin or insulin alone was not significantly different from 
control. Results are expressed as a mean ± S.D. (*, P < 0.05, Two-tailed t test with 
unequal variance compared with calvaria control, and ANOVA).  









Anova: Single Factor 
    
SUMMARY 
     




Control 4 0.706299 0.176575 0.000769   
Insulin  4 0.916364 0.229091 0.001788 
  
Calcitonin 4 1.021508 0.255377 0.00342 
  
Both  4 1.704951 0.426238 0.009721 
  
ANOVA 
      
Source of Variation SS df MS F P-value F crit 
Between Groups 0.140051 3 0.046684 11.89497 0.000659 3.490295 
Within Groups 0.047096 12 0.003925 
   
Total 0.187146 15 
    
Figure 4. Comparison of the means and associated standard deviations of osteoblast cells ALP activity for the four groups. From lowest to 
highest: Control, calcitonin, insulin, and then insulin and calcitonin. 
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Table 3. The mean depths of ALP activity differ significantly between groups which were subjected to different 

















Bone is continuously remodeled by the coupled process of  resorption and 
formation. Bone formation is regulated by osteoblasts, which are mononuclear, 
specialized cells that undergo a process of maturation in which genes such as Runx2 
play an important role. Moreover, osteoblasts have a very important role in creating 
and maintaining skeletal architecture. Bone structure and turnover are modulated by 
bone cells and affected by external factors such as drugs or hormones that may shift the 
remodeling equilibrium resulting in serious complications (Caetano-loes et al. 2007). 
The role of insulin and calcitonin on osteoblast function is not fully understood. There 
appear to be no studies in the literature in which the effect of insulin and calcitonin on 
osteoblast proliferation and biomineralization have been measured; therefore this study 
is the first attempt to investigate this issue. 
The first aim of this study was to determine the effect of insulin and calcitonin on 
osteoblast proliferation when added separately and in combination. Our results indicated 
either insulin or calcitonin alone is associated with a significant increase in osteoblast 
proliferation. However, the combination of hormones reduced the proliferation to control 
levels. Calcitonin has been shown to reduce serum insulin, possibly due to calcitonin leading 
to physiologic decrease in calcium levels which is an important factor for insulin transport 
and secretion (Petralito et al. 1979; Caviezel and Mangili 1984). The effect of insulin in 
combination with calcitonin on osteoblasts was unknown. Hence, more studies should 
investigate factors that reduced osteoblast proliferation when adding both calcitonin and 
insulin. 
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AA and BGP increase synthesis of collagen type I and osteocalcin, increase bone 
sialoprotein function, and ALP activity (Coelho et al. 2000). In the present study, we 
included these two compounds and added insulin, calcitonin, or both insulin and calcitonin 
to isolated osteoblast cultures to assess calcium uptake and ALP activity. 
The primary neonatal mouse osteoblasts co-cultured in the presence of AA and 
BGP with the three test groups showed a significant increase in calcium uptake compared 
to the control group. This finding suggests that certain hormones are necessary for 
osteoblast mediated biomineralization. Our finding collaborate studies in which calcium 
uptake in mouse calvaria was enhanced by insulin, most likely due to upregulation of 
calcium sensing receptor (Oh et al. 2016), and calcitonin (Wallach et al. 1993). However, 
insulin in excess was associated with decreased bone turnover (Tonks et al. 2017). The 
relationship between calcium uptake and insulin remains unclear since other studies have 
found no relationship between them (Hagstrom et al. 2007; Wareham et al. 1997).  
Even though there was a significant increase in calcium uptake for all tested groups, 
the ALP activity and amount of biomineralization were different. Only the combined insulin 
and calcitonin group showed a significant increase, which could be due to a limitation in our 
study in which a low sample size was included and a long period of incubation was used, 
which is 10 days, before testing. Our insulin group finding correlates with a study which 
found reduced effect of insulin, AA, and BGP on ALP activity (Fulzele et al. 2010). 
Calcitonin induced insulin receptor expression on osteoblast cells which may increase ALP 
activity (Saranteas et al. 2001). Combining AA and BGP resulted in a partial change in 
osteoblast ALP activity (Coelho and Fernandes 2000).  
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 Primary cells isolated from calvaria of fetal or new born rodents have been shown 
to be useful for in vitro studies of hormonal response (Wong and Cohn 1975). Osteoblast 
activity can be studied in a controlled environment free from the influence of other cell 
types normally found in bone, such as osteoclasts and haematopoietic cells (Brandao-
Burch et al. 2005), and effects of the extracellular environment, such as pH and pO2 
(Utting et al. 2006), which is very difficult to regulate in vivo. The in vitro assessment of 
mouse calvaria osteoblasts allows bone formation to be studied quantitatively.  Finally, 
osteoblasts can be studied at any stage of differentiation, such as the immature proliferating 
cells present early in the cultures, and the mature bone-forming osteoblasts in late-stage 
cultures (Orriss et al. 2014). 
Some limitations of this study include small sample size and short culture time.  The 
experimental groups in the experiment contained only four samples, therefore increasing 
sample size in the future may ensure consistency in the result and accuracy in the statistical 
analysis.  Extending the culture period may allow us to investigate the long-term effect of 
insulin and calcitonin together with AA and BGP on calvaria osteoblast proliferation and 
biominerlization.  Future direction of our studies will focus investigations of other 
hormones on mice calvarial osteoblasts with a large sample size.    
 22 
References 
1. Anderson HC. The role of matrix vesicles in physiological and pathological 
calcification. Current Opinion in Orthopaedics. 2007; 18(5):428-433. 
 
2. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, & Tabin C J. Genetic 
analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and 
skeletogenesis. PLOS Genetics. 2006; 2(12), e216. 
 
3. Batra N, Kar R, and Jiang JX. Gap junctions and hemichannels in signal 
transmission, function and development of bone. Biochimica et Biophysica Acta. 
2012; 18(8):1909-1918. 
 
4. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, 
Olson EN, et al. A twist code determines the onset of osteoblast differentiation. 
Developmental Cell. 2004; 6(3):423–435. 
 
5. Bellows CG, Aubin JE, Heershoe JNM, and Antosz ME. Mineralized bone nodules 
formed in vitro from enzymatically released rat calvaria cell population. Calcified 
Tissue International. 1986; 38(3):143-154. 
 
6. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, & 
MacDougald OA. Regulation of osteoblastogenesis and bone mass by 
Wnt10b. Proceedings of the National Academy of Sciences. 2005; 102(9):3324-
3329. 
 
7. Berg RA, Steinmann B, Rennard SI, Crystal RG. Ascorbate deficiency results in 
decreased collagen production: under-hydroxylation of proline leads to increased 
intracellular degradation. Archives of Biochemistry and Biophysics. 1983; 
226(2):681-686. 
 
8. Bhargava U, Bar-Lev M, Bellows CG, and Aubin JE. Ultrastructural analysis of 
bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone. 1988; 
9(3):155-163. 
 
9. Brandao-Burch A, Utting JC, Orriss IR and Arnett TR. Acidosis inhibits bone 
formation by osteoblasts in vitro by preventing mineralization. Calcified Tissue 
International. 2005; 77(3): 167-174. 
 
10. Caetano-Lopes J, Canhao H, & Eurico Fonseca J. Osteoblasts and bone 
formation. Acta Reumatológica Portuguesa. 2007; 32(2):103-110. 
 
11. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, ... & 
Milner LA. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 
2003; 425(6960): 841-846. 
 
 23 
12. Capulli M, Paone R, & Rucci N. Osteoblast and osteocyte: games without 
frontiers. Archives of Biochemistry and Biophysics. 2014. 561; 3-12. 
 
13. Caviezel F and Mangili R. Calcitonin and insulin secretion in normal man: Study 
with somatostatin and calcium. Acta Diabetologia Latina. 1984; 21(1), 41-46. 
  
14. Choong PF, Martin TJ, Ng KW. Effects of ascorbic acid, calcitriol, and retinoic 
acid on the differentiation of preosteoblasts. Journal of Orthopaedic Research. 
1993; 11(5):638-47.  
 
15. Chung CH, Golub EE, Forbes E, Tokuoka T, Shapiro IM. Mechanism of action of 
beta-glycerophosphate on bone cell mineralization. Calcified Tissue International. 
1992; 51(4):305-311. 
  
16. Coelho MJ and Fernandes MH. Human bone cell cultures in biocompatibility 
testing. Part II: effect of ascorbic acid, β-glycerophosphate and dexamethasone on 
osteoblastic differentiation. Biomaterials. 2000; 21(11): 1095-1102. 
 
17. Conte C, Epstein S, & Napoli N. Insulin resistance and bone: a biological 
partnership. Acta Diabetologica. 2018; 55(4):305-314. 
 
18. Cornish J, Callon KE, Cooper GJ, Reid IR. Amylin stimulates osteoblast 
proliferation and increases mineralized bone volume in adult mice. Biochemical 
and Biophysical Research Community. 1995; 207(1): 133–139. 
 
19. Cornish J, Callon KE, Gasser JA, Bava U, Gardiner EM, Coy DH, Cooper GJ, Reid 
IR. Systemic administration of a novel octapeptide, amylin-(1– 8), increases bone 
volume in male mice. American Journal of Physiology Endocrinology and 
Metabolism. 2000; 279(4): E730–E735. 
 
20. Cornish J, Naot D. Amylin and adrenomedullin: novel regulators of bone growth. 
Current Pharmaceutical Design. 2002; 8(23):2009–2021. 
 
21. Datta HK, Ng WF, Walker JA, Tuck SP, and Varanasi SS. The cell biology of bone 
metabolism.  Journal of Clinical Pathology. 2008; 61(5):577–587. 
 
22. Ecarot-Charrier B, Glorieux FH, van der Rest M, & Pereira G. Osteoblasts isolated 
from mouse calvaria initiate matrix mineralization in culture. Journal of Cell 
Biology. 1983; 96(3):639-643. 
 
23. Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Baylink DJ. The anti-bone-
resorptive agent calcitonin also acts in vitro to directly increase bone formation and 
bone cell proliferation. Journal of Endocrinology. 1988; 123(1):159–167. 
 
 24 
24. Fulzele K, Riddle RC, DiGirolamo DJ et al. Insulin receptor signaling in 
osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010; 
142(2):309–319. 
 
25. Garnero P and Delmas PD. Biochemical markers of bone turnover. Applications for 
osteoporosis. Endocrinology and Metabolism Clinics of North America. 1998; 
27(2):303-323. 
 
26. Golub EE, Harrison G, Taylor AG, Camper S, and Shapiro IM. The role of alkaline 
phosphatase in cartilage mineralization. Journal of Bone and Mineral Research. 
1992; 17(2):273-278. 
 
27. Golub EE and Boesze-Battaglia K. The role of alkaline phosphatase in 
mineralization. Current opinion in Orthopaedics. 2007; 18(5), 444-448. 
 
28. Grigoriadis AE, Heersche JN, & Aubin JE. Differentiation of muscle, fat, cartilage, 
and bone from progenitor cells present in a bone-derived clonal cell population: 
effect of dexamethasone. Journal of Cell Biology. 1988. 106(6):2139-2151. 
 
29. Hagstrom E, Hellman P, Lundgren E, Lind L, Arnlov J. Serum calcium is 
independently associated with insulin sensitivity measured with euglycaemic-
hyperinsulinaemic clamp in a community-based cohort. Diabetologia. 2007; 
50(2):317–24. 
 
30. Handschel J, Naujoks C, Langenbach F, Berr K, Depprich RA, Ommerborn MA, 
Kubler NR, Brinkmann M, Kogler G, Meyer U. Comparison of ectopic bone 
formation of embryonic stem cells and cord blood stem cells in vivo. Tissue 
Engineering Part A. 2010; 16(8):2475–2483. 
 
31. Hough FS, Pierroz DD, Cooper C, Ferrari SL, Bone IC. Mechanisms in 
endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes 
mellitus. European Journal of Endocrinology. 2016; 174(4):R127–R138. 
 
32. Huang S, Kaw M, Harris MT et al. Decreased osteoclastogenesis and high bone 
mass in mice with impaired insulin clearance due to liver-specific inactivation to 
CEACAM1. Bone. 2010; 46(4):1138–1145. 
 
33. Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007). Systematic review of 
type 1 and type 2 diabetes mellitus and risk of fracture. American Journal of 
Epidemiology 166(5):495–505. 
 
34. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, ... & Sato M. 
Targeted disruption of Cbfa1results in a complete lack of bone formation owing to 
maturational arrest of osteoblasts. Cell. 1997; 89(5):755-764. 
 
 25 
35. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, ... & Hsu H. 
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and 
activation. Cell. 1998; 93(2):165-176. 
 
36. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, ... & Karsenty 
G. Missense mutations abolishing DNA binding of the osteoblast-specific 
transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature genetics. 
1997; 16(3): 307-310. 
37. Liu J, Czernick D, Lin SC, Alasmari A, Serge D, Salih E. Novel bioactivity of 
phosvitin in connective tissue and bone organogenesis revealed by live calvarial 
bone organ culture models. Developmental biology. 2013; 381(1), 256-275. 
 
38. Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., ... & 
Komori, T. (2001). Overexpression of Cbfa1 in osteoblasts inhibits osteoblast 
maturation and causes osteopenia with multiple fractures. Journal of Cell 
Biology, 155(1):157-166. 
 
39. Miao D and Scutt A. Histochemical localization of alkaline phosphatase activity in 
decalcified bone and cartilage. Journal of Histochemistry and Cytochemistry. 2002; 
50(3), 333-340. 
 
40. Nakamura H. Morphology, function, and differentiation of bone cells. Journal of 
Hard Tissue Biology. 2007; 16(1):15-22. 
  
41. Naot D, Musson DS, and Cornish J. The Activity of Peptides of the Calcitonin 
Family in Bone. Physiological Reviews. 2019; 99(1)781-805. 
 
42. Oh YS, Seo EH, Lee YS, Cho SC, Jung HS, Park SC, & Jun HS. Increase of 
calcium sensing receptor expression is related to compensatory insulin secretion 
during aging in mice. PlOS one. 2016; 11(7):e0159689. 
 
43. Orriss IR, Hajjawi MO, Huesa C, MacRae VE, & Arnett TR. Optimisation of the 
differing conditions required for bone formation in vitro by primary osteoblasts 
from mice and rats. International Journal of Molecular Medicine. 
2014; 34(5):1201-1208. 
 
44. Petralito A, Lunetta M, Liuzzo A, Fiore CE, & Heynen G. Effects of salmon 
calcitonin on blood glucose and insulin levels under basal conditions and after 
intravenous glucose load. Journal of Endocrinological Investigation. 
1979; 2(2):209-211. 
 
45. Robling AG, Castillo AB, and Turner CH. Biomechanical and molecular regulation 
of bone remodeling. Annual Review of Biomedical Engineering. 2006; 8:455–498. 
 
46. Saranteas T, Mourouzis C, Mezitis M, Tesseromatis C, & Spyraki C. Interaction 
between nandrolone decanoate and calcitonin in bone formation markers 
 26 
(osteocalcin and bone specific alkaline phosphatase) and IGF-I in rats. Journal of 
Musculoskeletal and Neuronal Interactions. 2001; 2(2):167-170. 
 
47. Shapiro F. Variable conformation of GAP junctions linking bone cells: a 
transmission electron microscopic study of linear, stacked linear, curvilinear, oval, 
and annular junctions. Calcified Tissue International. 1997; 61(4):285-293. 
 
48. Shen B, Wei A, Whittaker S, Williams LA, Tao H, Ma DD, & Diwan AD. The role 
of BMP‐7 in chondrogenic and osteogenic differentiation of human bone marrow 
multipotent mesenchymal stromal cells in vitro. Journal of Cellular Biochemistry. 
2010; 109(2):406-416. 
 
49. Shyu JF, Shih C, Tseng CY, Lin CH, Sun DT, Liu HT, Tsung HC, Chen TH, Lu 
RB. Calcitonin induces podosome disassembly and detachment of osteoclasts by 
modulating Pyk2 and Src activities. Bone. 2007. 40(5):1329–1342. 
 
50. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, ... & 
Shimamoto G. Osteoprotegerin: a novel secreted protein involved in the regulation 
of bone density. Cell. 1997; 89(2):309-319. 
 
51. Tada H, Nemoto E, Foster BL, Somerman MJ, Shimauchi H. Phosphate increases 
bone morphogenetic protein-2 expression through cAMPdependent protein kinase 
and ERK1/2 pathways in human dental pulp cells. Bone. 2011; 48(6):1409–1416. 
 
52. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an 
anabolic agent in bone? Dissecting the diabetic bone for clues. American Journal of 
Physiology Endocrinology Metabolism. 2005; 289(5):E735–E745. 
 
53. Tonks KT, White CP, Center JR, Samocha-Bonet D, Greenfield JR. Bone turnover 
is suppressed in insulin resistance, independent of adiposity. Journal of Clinical 
Endocrinology and Metabolism. 2017; 102(4):1112–1121. 
 
54. Utting JC, Robins SP, Brandao-Burch A, Orriss IR, Behar J and Arnett TR. 
Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat 
osteoblasts. Experimental Cell Research. 2006; 312(10):1693-1702. 
 
55. Vater C, Kasten P, Stiehler M. Culture media for the differentiation of 
mesenchymal stromal cells. Acta Biomaterialia. 2011; 7(2):463–477. 
 
56. Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F, Guidobono F. Human 
osteoblast-like cell proliferation induced by calcitonin-related peptides involves 




57. Wallach S, Farley JR, Baylink, DJ, & Brenner-Gati L. Effects of calcitonin on bone 
quality and osteoblastic function. Calcified Tissue International. 1993. 52(5):335-
339. 
 
58. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose 
intolerance is associated with altered calcium homeostasis: a possible link between 
increased serum calcium concentration and cardiovascular disease mortality. 
Metabolism: clinical and experimental. 1997; 46(10):1171–1177. 
 
59. Weiss RE, Singer FR, Gorn AH, Hofer DP, Nimni ME. Calcitonin stimulates bone 
formation when administered prior to initiation of osteogenesis. Journal of Clinical 
Investigation. 1981; 68(3):815–818. 
 
60. Wong GL and Cohn DV. Target cells in bone for parathormone and calcitonin are 
different: enrichment for each cell type by sequential digestion of mouse calvaria 
and selective adhesion to polymeric surfaces. Proceedings of the National Academy 
of Sciences of the United States of America. 1975; 72(8):3167-3171. 
 
61. Yellowley CE, Li Z, Zhou Z, Jacobs CR, and Donahue HJ. Functional gap 
junctions between osteocytic and osteoblastic cells. Journal of Bone and Mineral 
Research. 2000; 15(2): 209-217. 
 
62. Ypey DL, Weidema AF, Hold KM, Van der Laarse A, Ravesloot JH, Van Der Plas 
A, Nijweide PJ. Voltage, calcium, and stretch activated ionic channels and 
intracellular calcium in bone cells. Journal of Bone and Mineral Research. 1992; 
7(2): S377-387. 
 
63. Young MF, Kerr JM, Ibaraki K, Heegaard AM, and Robey PG. Structure, 
expression, and regulation of the major noncollagenous matrix proteins of bone. 
Clinical Orthopaedics and Related Research. 1992; 281:275-294. 
 
64. Zhang Z, Neff L, Bothwell AL, Baron R, Horne WC. Calcitonin induces 
dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in 










                                                                                                      
 31 
                                                                                       
 32 
                                                                                   
 33 
                                                                                           
                                                                                           
                                                                                           
 34 
